Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Nov 1;1(11):483-485.
doi: 10.5588/ijtldopen.24.0333. eCollection 2024 Nov.

Accelerating TB regimen development: introducing FAST-TB

T Devezin  1 , C Chisholm  1 , F Jones  2 , K Lacourciere  2 , B Laughon  3 , L Ramachandra  3 , A Vernon  2 , L Zhang  2 , P Kim  2 , C Lienhardt  1
Affiliations
Editorial

Accelerating TB regimen development: introducing FAST-TB

T Devezin et al. IJTLD Open. .
No abstract available

Keywords: drug development; drugs; therapeutics; tuberculosis.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
FAST-TB leadership structure. FAST-TB = Facilitating accelerated science and translation for TB regimen development.
Figure 2.
Figure 2.
FAST-TB track communication flow. KITT = Knowledge Integration for TB Treatment development; GoFAST = Global Forum for biomarkers to Accelerate TB Treatment Development; PACE = Population and Cost-effectiveness Modeling Core; RELAY = Research to Translate and Yield Evidence into Practice; FAST-TB = Facilitating accelerated science and translation for TB regimen development.
See this image and copyright information in PMC

References

    1. Working Group for New TB Drugs, Stop TB Partnership . Clinical Pipeline. New York, NY, USA: Working Group for New TB Drugs, 2024. https://www.newtbdrugs.org/pipeline/clinical
    1. World Health Organization . WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-susceptible tuberculosis treatment. Geneva, Switzerland: WHO, 2022. - PubMed
    1. Migliori GB, Tiberi S. WHO drug-resistant TB guidelines 2022: what is new? Int J Tuberc Lung Dis. 2022;26(7):590–591. - PubMed
    1. World Health Organization . WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update. Geneva, Switzerland: WHO, 2022. - PubMed
    1. Motta I, et al. . Recent advances in the treatment of tuberculosis. Clin Microbiol Infect. 2024;30(9):1107-1114. - PubMed

Publication types

LinkOut - more resources